We present the physical properties of AKARI sources without optical counterparts in optical images from the Hyper Suprime-Cam (HSC) on the Subaru telescope. Using the AKARI infrared (IR) source catalog and HSC optical catalog, we select 583 objects that do not have HSC counterparts in the AKARI North Ecliptic Pole (NEP) wide survey field (∼ 5 deg 2). Because the HSC limiting magnitude is deep (g AB ∼ 28.6), these are good candidates for extremely red star-forming galaxies (SFGs) and/or active galactic nuclei (AGNs), possibly at high redshifts. We compile multi-wavelength data out to 500 µm and use it for Spectral Energy Distribution (SED) fitting with CIGALE to investigate the
We present an 850-μm mosaic map and extracted catalogue of submillimetre sources in the extended North Ecliptic Pole (NEP) region over about 2 deg2. The 850-μm map is constructed using newly obtained observations by SCUBA-2 at the East Asian Observatory’s James Clerk Maxwell Telescope, carried out using the observatory’s large programme opportunities. The recent 850-μm survey has extended the submillimetre data coverage by almost a factor of 4 compared to previous surveys, with a depth of σrms = 1.0–2.3 mJy beam−1. The catalogue contains 549 sources selected above a significance level of 4σ, where the false-detection rate is 10 per cent; a higher threshold of 4.5σ is required in order to achieve a false-detection rate below 3 per cent, which results in 342 sources being selected. Despite the large spatial variation of the noise, the deboosted flux density of sources is comparable to results from the SCUBA-2 Cosmology Legacy Survey (S2CLS), which covered the central 0.6 deg2 of our survey area with better sensitivity. We construct the source counts at 850 μm, finding results in agreement with other 850-μm surveys in cosmological blank fields over S850 = 4–15 mJy. We find a slight excess of bright galaxies (S850 > 15 mJy), which can be considered to be at zphot = 2–4. The 850-μm data adds valuable long-wavelength information to mid-infrared-selected sources from the AKARI NEP-deep and NEP-wide surveys, which will be helpful in preparing for future near-infrared to millimetre wavelength observations in the NEP region. Our 850-μm mosaic map and source catalogue will be made publicly available.
The AKARI infrared (IR) space telescope conducted two surveys (Deep and Wide) in the North Ecliptic Pole (NEP) field to find more than 100,000 IR sources using its Infrared Camera (IRC). IRC’s 9 filters, which cover wavebands from 2 to 24 μm continuously, make AKARI unique in comparison with other IR observatories such as Spitzer or WISE. However, studies of the AKARI NEP-Wide field sources had been limited due to the lack of follow-up observations in the ultraviolet (UV) and optical. In this work, we present the Canada-France-Hawaii Telescope (CFHT) MegaPrime/MegaCam u-band source catalogue of the AKARI NEP-Wide field. The observations were taken in 7 nights in 2015 and 2016, resulting in 82 observed frames covering 3.6 deg2. The data reduction, image processing and source extraction were performed in a standard procedure using the Elixir pipeline and the AstrOmatic software, and eventually 351,635 sources have been extracted. The data quality is discussed in two regions (shallow and deep) separately, due to the difference in the total integration time (4,520 and 13,910 seconds). The 5σ limiting magnitude, seeing FWHM, and the magnitude at 50 per cent completeness are 25.38 mag (25.79 mag in the deep region), 0.82 arcsec (0.94 arcsec) and 25.06 mag (25.45 mag), respectively. The u-band data provide us with critical improvements to photometric redshifts and UV estimates of the precious infrared sources from the AKARI space telescope.
Purpose The aim of this study was to evaluate the impact of polydeoxyribonucleotide (PDRN) on histologic outcomes when implant placement and lateral sinus floor elevation are performed simultaneously. Methods Three bimaxillary premolars (P2, P3, and P4) were extracted from 4 beagle dogs 2 months before lateral sinus floor elevation. After lateral elevation of the sinus membrane, each sinus was allocated to either the test or control group. Sinuses underwent either 1) collagenated synthetic bone graft with PDRN following lateral sinus floor elevation (test group) or 2) collagenated synthetic bone graft without PDRN after lateral sinus floor elevation (control group). Eight weeks after the surgical procedure, all animals were euthanised for a histologic and histomorphometric assessment. Augmented height (AH), protruding height (PH), and bone-to-implant contact in pristine (BIC p ) and augmented (BIC a ) bone were measured. The composition of the augmented area, which was divided into 3 areas of interest located in coronal, middle and apical areas (AOI_C, AOI_M, and AOI_A), was calculated with 3 parameters: the area percentage of new bone (pNB), residual bone graft particle (pRBP), and fibrovascular connective tissue (pFVT). Results AH, PH, BIC p , BIC a total, BIC a coronal, and BIC a middle values were not significantly different between sinuses in the control and test groups (all P >0.05). The BIC a apical of sinuses in the test group (76.7%±9.3%) showed statistically higher values than those of sinuses in the control group (55.6%±22.1%) ( P =0.038). pNB, pRBP, and pFVT showed statistically significant differences between the 2 groups in AOI_A ( P =0.038, P= 0.028, and P= 0.007, respectively). pNB, pRBP, and pFVT in AOI_C and AOI_M were not significantly different between samples in the control and test groups (all P >0.05). Conclusions The histologic findings revealed that lateral sinus floor elevation with PDRN might improve early new bone formation and enable higher bone-to-implant contact.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.